That is the bottom line and nothing else. Merger with a cash starved micro with a very promising pre/in clinic pipeline or small currently marketed product portfolio with synergies complementary to CBRX , outright acquisition of an entity, or the least likely sale of the company is all speculation and doesn't much matter at this juncture.
The reason is simple! The stock is worth between 8.75 - 9.50 right now conservatively. That, also conservatively values the company at somewhere in the 100M MC area based on tangible metrics that would still lag average valuations in the space.
The MB personality, who will remain nameless, is doing a feeble job of blowing smoke as well as substantiating the well deserved label as an idiot supreme, but it's nothing new.
PS, adding quantity on ANYTHING at or under 1 X EV/SALES (you do the recalc post RS)! I suggest others do the same!